About the
NeLM
|
Help & Support
|
Site Feedback
|
Update Newsletter Subscription
Homepage
Login
|
Register
Search the NeLM
Medicines A-Z
Find key information about medicines by name (prototype)
Browse by Categories:
BNF Category
|
Medical Specialty
|
National Health Service
|
Medicines Information
Browse by NeLM area:
Evidence
|
Other Library Updates
|
News
|
Health In Focus
|
Medicines A-Z
|
Communities
|
Useful Links
|
Formularies
Medical Specialty
Anaesthesia
Bone Diseases
Cardiovascular Medicine
Care of Older People
Cerebrovascular Disorders
Complementary Medicine
Dentistry
Dermatology
Ear, Nose and Throat (ENT) disorders
Emergency Medicine
Endocrinology
Family planning
Gastroenterology
Geriatric Medicine
Haematology
Immunology and vaccination
Infections
Infectious Diseases
Intensive Care (ICU)
Liver disease
Menopause / hormone replacement therapy (HRT)
Mental Health
Neurology
Nutrition and Metabolism
Obstetrics & Gynaecology
Oncology
Ophthalmology
Paediatrics
Pain control
Palliative care
Preventative medicines
Radiology
Renal medicine
Reproductive medicine
Respiratory Medicine
Rheumatology
Sports medicine
Surgery
Travel medicine
Urology
Wound Management
Cancer: bladder
Cancer: brain
Cancer: breast
Cancer: gastroenterological
Cancer: gynaecological
Cancer: haematological
Cancer: kidney
Cancer: lung
Cancer: other
Cancer: pancreas
Cancer: prostate
Cancer: skin
Leukaemia
Lymphoma
Radiotherapy
Multiple myeloma
178 library items
in Cancer: haematological
Filter results by:
Date Published
2012 (7)
2011 (40)
2010 (34)
2009 (31)
2008 (30)
More
NeLM
Area
News
Other Library Updates
Health In Focus
Evidence
Medicines A-Z
Communities
Formularies
Results filtered by:
Category
Oncology (
remove
)
,
Cancer: haematological (
remove
)
Sort by:
Least recent publication date
Most recent publication date
Title alphabetical A-Z
Title alphabetical Z-A
Source alphabetical A-Z
Source alphabetical Z-A
Display summary:
No
Yes
Results 1 - 10 of 178
Result page:
Previous
|
1
2
3
4
5
6
7
8
9
10
11
|
Next
1.
Bortezomib added to thalidomide and dexamethasone (TD) associated with superior efficacy outcomes in MM patients progressing or relapsing after stem cell transplantation
Source:
Journal of Clinical Oncology
,
Date published:
16/05/2012
Category:
8.1.5 Other antineoplastic drugs
|
Multiple myeloma
NeLM
Area:
News
Abstract
2.
RCTs of continuous lenalidomide treatment for multiple myeloma
Source:
New England Journal of Medicine (NEJM)
,
Date published:
10/05/2012
Category:
8.2.4 Other immunomodulating drugs
|
Multiple myeloma
|
Transplantation
NeLM
Area:
News
Abstract (newly diagnosed)
Abstract (stem cell transplantation 1)
Abstract (stem cell transplantation 2)
Editorial- full text may be restricted to subscribers
3.
FDA Drug Safety Communication: Increased risk of second primary malignancies in patients taking lenalidomide for multiple myeloma
Source:
FDA MedWatch
,
Date published:
08/05/2012
Category:
8.2.4 Other immunomodulating drugs
|
Adverse Drug Reactions
|
Food &Drug Administration (FDA)
|
Multiple myeloma
NeLM
Area:
News
Link
4.
Vidaza 25mg/ml powder for suspension (azacitidine) Revised SPC
Source:
eMC (electronic Medicines Compendium)
,
Date published:
08/03/2012
Category:
8.1.3 Antimetabolites
|
Multiple myeloma
|
Product Licence Changes
NeLM
Area:
Other Library Updates
>
SPC Changes
SPC
5.
Lancet Series: Malignancies in pregnancy
Source:
Lancet
,
Date published:
10/02/2012
Category:
8.1 Cytotoxic drugs
|
Cancer: breast
|
Cancer: gynaecological
|
Cancer: haematological
|
Drugs in pregnancy
|
Obstetrics &Gynaecology
NeLM
Area:
News
Series homepage
Gynaecological cancers in pregnancy – abstract
Breast cancer in pregnancy - abstract
Haematological cancers in pregnancy - abstract
6.
EMA issues recommendations to prevent administration errors with bortezomib
Source:
EMA
,
Date published:
20/01/2012
Category:
8.1.5 Other antineoplastic drugs
|
Drug Administration
|
European Agency for the Evaluation of Medicinal Products (EMEA)
|
Medication errors
|
Multiple myeloma
NeLM
Area:
News
Link
Letter from Janssen
7.
Horizon scanning: Therapeutic cytomegalovirus DNA vaccine in allogeneic haemopoietic stem-cell transplantation: a randomised, double-blind, placebo-controlled, phase II trial
Source:
Lancet Infectious Diseases
,
Date published:
10/01/2012
Category:
14.4 Vaccines and antisera
|
Cancer: haematological
|
Vaccination
NeLM
Area:
News
Abstract
Editorial
8.
Horizon scanning: Follow up data for phase III study of lenalidomide in patients with high-risk smoldering multiple myeloma
Source:
BioSpace
,
Date published:
20/12/2011
Category:
8.2.4 Other immunomodulating drugs
|
Licence extension
|
Multiple myeloma
NeLM
Area:
News
Abstract
9.
Systematic review and economic evaluation: Bortezomib and thalidomide in combination regimens with an alkylating agent and a steroid for first-line
Source:
Health Technology Assessment (HTA)
,
Date published:
15/12/2011
Category:
8.1.5 Other antineoplastic drugs
|
8.2.4 Other immunomodulating drugs
|
Drug reviews
|
Multiple myeloma
NeLM
Area:
Evidence
>
Drug Specific Reviews
Link
10.
Final 5-year results for VISTA trial show that bortezomib extends survival in untreated multiple myeloma
Source:
BioSpace
,
Date published:
14/12/2011
Category:
8.1.1 Alkylating drugs
|
8.1.5 Other antineoplastic drugs
|
8.2.4 Other immunomodulating drugs
|
Multiple myeloma
NeLM
Area:
News
Biospace abstract
NELM abstract of VISTA
Results 1 - 10 of 178
Result page:
Previous
|
1
2
3
4
5
6
7
8
9
10
11
|
Next